LCG
Lisanti Capital Growth’s Tandem Diabetes Care TNDM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.73M | Buy |
+253,840
| New | +$4.73M | 1.31% | 30 |
|
|
2025
Q1 | – | Sell |
-118,550
| Closed | -$4.27M | – | 158 |
|
|
2024
Q4 | $4.27M | Buy |
118,550
+3,625
| +3% | +$131K | 1.03% | 39 |
|
|
2024
Q3 | $4.87M | Sell |
114,925
-43,335
| -27% | -$1.84M | 1.23% | 29 |
|
|
2024
Q2 | $6.38M | Sell |
158,260
-16,570
| -9% | -$668K | 1.53% | 15 |
|
|
2024
Q1 | $6.19M | Buy |
174,830
+68,935
| +65% | +$2.44M | 1.51% | 12 |
|
|
2023
Q4 | $3.13M | Buy |
+105,895
| New | +$3.13M | 0.74% | 63 |
|
|
2022
Q3 | – | Sell |
-43,572
| Closed | -$2.58M | – | 137 |
|
|
2022
Q2 | $2.58M | Sell |
43,572
-81,082
| -65% | -$4.8M | 0.35% | 87 |
|
|
2022
Q1 | $14.5M | Buy |
124,654
+49,154
| +65% | +$5.72M | 1.63% | 13 |
|
|
2021
Q4 | $11.4M | Buy |
75,500
+22,600
| +43% | +$3.4M | 1.64% | 10 |
|
|
2021
Q3 | $6.32M | Buy |
52,900
+11,580
| +28% | +$1.38M | 0.93% | 38 |
|
|
2021
Q2 | $4.03M | Buy |
+41,320
| New | +$4.03M | 0.5% | 82 |
|
|
2020
Q4 | – | Sell |
-100,345
| Closed | -$11.4M | – | 147 |
|
|
2020
Q3 | $11.4M | Buy |
100,345
+41,402
| +70% | +$4.7M | 2.11% | 3 |
|
|
2020
Q2 | $5.83M | Sell |
58,943
-31,138
| -35% | -$3.08M | 1.19% | 26 |
|
|
2020
Q1 | $5.8M | Buy |
90,081
+26,314
| +41% | +$1.69M | 1.91% | 8 |
|
|
2019
Q4 | $3.8M | Sell |
63,767
-23,668
| -27% | -$1.41M | 1.01% | 40 |
|
|
2019
Q3 | $5.16M | Sell |
87,435
-10,890
| -11% | -$642K | 1.68% | 21 |
|
|
2019
Q2 | $6.34M | Buy |
98,325
+51,070
| +108% | +$3.3M | 2.06% | 9 |
|
|
2019
Q1 | $3M | Sell |
47,255
-13,850
| -23% | -$880K | 1.06% | 36 |
|
|
2018
Q4 | $2.32M | Buy |
61,105
+24,130
| +65% | +$916K | 0.94% | 50 |
|
|
2018
Q3 | $1.58M | Buy |
+36,975
| New | +$1.58M | 0.55% | 76 |
|
|
2014
Q1 | – | Sell |
-19,425
| Closed | -$501K | – | 124 |
|
|
2013
Q4 | $501K | Buy |
+19,425
| New | +$501K | 0.21% | 100 |
|